相关实验视频
Updated: Feb 26, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
1.0K
耐火坟墓的产前管理"甲状腺毒性病"
Sonam Tshering1, Ashutosh Kapoor1, Sophie Buckley1
1Endocrinology and Diabetes, Barts Health NHS Trust, London, GBR.
Cureus
|February 25, 2026
概括
在怀孕期间管理耐火格雷夫斯病是复杂的. 这一案例凸显了抗甲状腺药物的挑战和绝对治疗的风险,强调了严重甲状腺功能障碍症的个性化护理.
科学领域:
- 内分泌学 在内分泌学.
- 内部医学 内部医学
- 产科 产科 产科 产科 产科
背景情况:
- 格雷夫斯病是甲状腺功能障碍的主要原因,通常用抗甲状腺药物 (ATD),放射性 (RAI) 或手术治疗.
- 耐火性甲状腺毒性和怀孕由于免疫变化和治疗局限性而带来独特的管理挑战.
- 严重的,持续的格雷夫斯甲状腺毒性炎症耐高剂量甲甲 (PTU) 复杂化周围护理.
研究的目的:
- 在怀孕和产后期间呈现严重,耐火的格雷夫斯甲状腺毒性病例.
- 为了说明围产期管理困难的格雷夫斯病病例所带来的复杂性和风险.
- 强调需要多学科和个性化的治疗策略.
主要方法:
- 一份病例报告详细介绍了一名39岁的耐火格雷夫斯病患者的临床过程.
- 管理涉及高剂量的PTU,醇,并最终放射性 (RAI) 治疗.
- 评估包括生物化学甲状腺激素水平,TSH受体抗体,并监测并发症.
主要成果:
- 尽管在怀孕期间服用高剂量的PTU,但患者仍然患有甲状腺功能过高,经历了妊娠高血压和胎儿口腔裂纹.
- 产后,她患有抑郁症和恶化的甲状腺毒性病,由于并发症和高手术风险,最终治疗选择有限.
- 放射性治疗最初成功地实现了轻甲状腺症,但在九个月后发生了复发.
结论:
- 在分娩前期管理耐火格雷夫斯甲状腺毒性病是具有挑战性的,特别是当传统疗法失败时.
- 像手术和RAI这样的绝对治疗方法在这个人群中具有较高的风险.
- 在复杂的病例中,以患者为中心的多学科方法对于个性化管理策略至关重要.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
8.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.3K
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.0K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.0K
Dysrhythmias VI: Management of Dysrhythmias
544
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
544
Dysrhythmias VII: Nursing Management of Dysrhythmias
460
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
460
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
697
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
697
Cardiomyopathy VII: Pre and Post Operative Nursing Management
398
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
398

